FDA Inspection
Ascend Laboratories, LLCAscend Laboratories, LLC – FDA Inspection, Dec 11, 2013
Record Details
This FDA Inspection record concerns Ascend Laboratories, LLC, with an inspection on December 11, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ascend Laboratories, LLC
- Inspection Date
- December 11, 2013
- Product Type
- Drugs
View Company Profile
ID · 85e45936-fa57-45e6-aa37-7280a8c4e056
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 856772
- FDA center
- Human Drugs
- Project area
- Unapproved and Misbranded Drugs
FDA Citations
4- 21 CFR 211.150(b)Recall facilitation
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.198(a)Procedures to be written and followed
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ascend Laboratories, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| November 10, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 24, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 6, 2017 | NAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| February 10, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ascend Laboratories, LLC
- FDA Inspection 1156395 - 2021-11-10
- FDA Inspection 1144680 - 2021-06-24
- FDA Inspection 1023638 - 2017-07-06
- FDA Inspection 709952 - 2011-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.